The 80-Watt COOLIEF* Radiofrequency (RF) system for neurological lesion procedures has received marketing clearance from the US Food and Drug Administration, Avanos Medical announces.
The system, comprised of a newly designed RF generator, peristaltic pump and therapy cables, is designed to enable physicians to perform procedures including Cooled, Standard, Pulsed, TransDiscal and dual Bipolar RF.
Cooled RF is a non-opioid, minimally invasive outpatient pain management procedure that uses cooled radiofrequency energy to safely treat chronic pain by targeting the sensory nerves causing pain, according to the company in the release.
This new system, which reportedly provides 60% more power than the legacy system, features an intuitive touchscreen interface, and independent channel control that enables physicians to start, stop and adjust on four probes individually, which enhances ease of use and efficiency, the release continues.
“For over a decade, Avanos has been committed to driving innovation and investing in clinical evidence in RF technology,” states Joe Woody, Avanos’ chief executive officer. “The addition of our new, advanced COOLIEF* RF generator demonstrates this continued commitment to introduce innovation to the marketplace as the Cooled RF authority and to provide relevant solutions that help patients effectively manage pain without the risk of addiction, so they can get back to things that matter.”
[Source(s): Avanos Medical, PR Newswire]
